by Lee F. Schroeder, Jeannette Guarner, Ali Elbireer et al.
N Engl J Med 2016; 374:2511-2514, June 30, 2016
4 pp. 120 kB
The Model List of Essential Medicines (EML) maintained by the World Health Organization (WHO) plays a central role in global health policy. The authors believe that it is time to establish a similarly influential Model List of Essential Diagnostics (EDL). Diagnostic tests are critical to the management of communicable and non-communicable diseases, surveillance of emerging infectious threats such as the Ebola and Zika viruses, and the safe and rational use of EML medicines, including stewardship of antiinfective agents to reduce the likelihood of the development of microbial resistance. Wherever the list is housed, its existence would facilitate group purchasing to reduce costs and inspire development of logistical solutions for laboratory testing in resource-poor settings.